Skip to main content
ACAD logo

ACAD · Acadia Pharmaceuticals Inc · Executive Compensation

Track ACAD — free
$20.21 +0.06 (+0.30%)
Market Cap
$3.44B
Shares
172.31M
Volume · Sep 30 3.13M Avg daily vol (3M) 1.77M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Catherine Owen $8,256,518
Mark C $3,119,408
Jennifer J $2,927,897
Elizabeth H.Z $2,888,383
Thomas Garner $857,023
Fiscal 2024
Executive Total
Stephen R $12,206,915
Catherine Owen $7,594,107
Elizabeth H.Z $4,261,944
Thomas Garner $3,670,951
Jennifer J $3,267,348
Mark C $2,517,513
Fiscal 2023
Executive Total
Stephen R $7,587,014
Douglas J $4,588,693
Brendan P $2,618,590
Mark C $2,591,204
Austin D. Kim $2,024,546
Thomas Garner —
Catherine Owen —
Elizabeth H.Z —
Jennifer J —
Fiscal 2022
Executive Total
Stephen R $14,028,139
Stephen Davis $14,028,139
Srdjan Stankovic $7,797,628
Austin D. Kim $4,537,092
Mark C. Schneyer $2,353,204
Mark Schneyer $2,353,204
Mark C $2,353,204
Brendan Teehan $2,297,810
Brendan P. Teehan $2,297,810
Brendan P $1,167,152
Jennifer J —
Douglas J —
Thomas Garner —
Elizabeth H.Z —
Catherine Owen —
Fiscal 2021
Executive Total
Stephen R $9,793,289
Stephen Davis $9,793,289
Srdjan Stankovic $4,869,637
Mark C. Schneyer $3,182,819
Mark Schneyer $3,182,819
Mark C $3,182,819
Brendan P $2,474,115
Brendan P. Teehan $2,474,115
Brendan Teehan $2,474,115
Elena Ridloff $2,389,704
Austin D. Kim $2,330,704
General Counsel $2,330,704
Douglas J —
Fiscal 2020
Executive Total
Stephen Davis $7,763,187
Srdjan Stankovic $4,856,415
Michael Yang $2,620,679
Elena Ridloff $2,514,170
Austin D. Kim $1,747,288
General Counsel $1,747,288
Fiscal 2019
Executive Total
Stephen Davis $7,631,245
Srdjan Stankovic $5,088,270
Michael Yang $2,943,821
Elena Ridloff $1,990,867
General Counsel $1,906,126
Fiscal 2018
Executive Total
Stephen Davis $6,508,032
Srdjan Stankovic $5,678,381
Michael Yang $3,182,910
General Counsel $2,126,212

Executive changes

Person Change Filed
Adora Ndu, Pharm.D., J.D. Appointed 2026-05-29
Edmund P. Harrigan, M.D. Appointed 2026-05-29
James M. Daly Appointed 2026-05-29
Jonathan M. Poole Appointed 2026-03-05
Daniel B. Soland Resigned 2025-11-03
Brendan Teehan Terminated 2024-11-20
Catherine Owen Adams Appointed 2024-09-23
Catherine Owen Adams Appointed 2024-09-23
Stephen R. Davis Resigned 2024-09-23
Stephen R. Davis Terminated 2024-09-23
Daniel B. Soland Appointed 2024-05-29
Stephen R. Biggar, M.D., Ph.D. Appointed 2024-05-29
Julian C. Baker Appointed 2024-05-29
Srdjan R. Stankovic, M.D., M.S.P.H. Retired 2022-10-28
Adora Ndu, Pharm.D., J.D. Appointed 2022-10-13
Key facts CIK 1070494 CUSIP 004225108 13F (30d) 14 filings 11 filers Visit website Investor relations